Tretazicar Uses, Dosage, Side Effects and more
Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).
| Trade Name | Tretazicar |
| Generic | Tretazicar |
| Tretazicar Other Names | Tretazicar |
| Type | |
| Formula | C9H8N4O5 |
| Weight | Average: 252.1836 Monoisotopic: 252.049469386 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
